Cytokinetics shares owned by Emerald Advisers
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Emerald Advisers
from 13F filings
Historical chart of Emerald Advisers investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Emerald Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $13M | 199k | 65.91 |
| 2024-03-31 | $6.4M | 92k | 70.11 |
| 2023-03-31 | $8.4M | 238k | 35.19 |
| 2022-12-31 | $22M | 472k | 45.82 |
| 2022-09-30 | $17M | 341k | 48.45 |
| 2022-06-30 | $5.7M | 144k | 39.29 |